Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,232,143 papers from all fields of science
Search
Sign In
Create Free Account
Prior Hormone Therapy
Known as:
prior hormonal therapy
An indication that an individual has been previously treated with hormonal therapy.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phase II pilot trial of imatinib mesylate with weekly docetaxel in metastatic breast cancer
J. Barton
,
W. Liggett
,
+5 authors
D. Yardley
2006
Corpus ID: 221198784
10716 Background: Overexpression of platelet derived growth factor receptor (PDGFR) has been associated with breast cancer tumor…
Expand
2004
2004
Final results of a phase II study of weekly trastuzumab and vinorelbine in chemonaive patients with HER2-overexpressing metastatic breast cance.
G. Bernardo
,
R. Palumbo
,
+5 authors
I. Jedrychowska
Journal of Clinical Oncology
2004
Corpus ID: 22362729
731 Background: Activity of Trastuzumab (T) and Vinorelbine (VNR) in patients (pts) with HER2+ metastatic breast cancer (MBC) has…
Expand
2003
2003
Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer
P. Escobar
,
M. Markman
,
K. Zanotti
,
K. Webster
,
J. Belinson
Journal of Cancer Research and Clinical Oncology
2003
Corpus ID: 22046597
PurposeTo evaluate the efficacy and toxicity of pegylated liposomal doxorubicin in patients with advanced endometrial cancer…
Expand
Review
2000
Review
2000
Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.
W. Zhang
,
I. Sesterhenn
,
R. Connelly
,
F. Mostofi
,
J. Moul
Journal of Urology
2000
Corpus ID: 34311990
1999
1999
α-Difluoromethylornithine as Treatment for Metastatic Breast Cancer Patients
J. O’Shaughnessy
,
L. Demers
,
+6 authors
A. Manni
1999
Corpus ID: 19151991
DFMO (α-difluoromethylornithine) is an oral irreversible inhibitor of ornithine decarboxylase, the first rate-limiting enzyme in…
Expand
Highly Cited
1999
Highly Cited
1999
Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy.
L. Pisters
,
P. Perrotte
,
S. Scott
,
G. Greene
,
A. V. von Eschenbach
Journal of Clinical Oncology
1999
Corpus ID: 39985358
PURPOSE Our objective was to identify clinical pretreatment factors associated with early treatment failure after salvage…
Expand
Highly Cited
1998
Highly Cited
1998
Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose.
R. Valicenti
,
L. Gomella
,
+5 authors
J. Lu
Urology
1998
Corpus ID: 24650011
1996
1996
Single-agent paclitaxel as first-line treatment of metastatic breast cancer: the British experience.
N. Davidson
Seminars in Oncology
1996
Corpus ID: 20281350
The efficacy and safety of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) was studied as first-line treatment…
Expand
1996
1996
A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer.
N. Davidson
,
J. Chick
,
T. Perren
,
N. Campbell
,
J. Thompson
,
Y. Chan
Clinics in oncology
1996
Corpus ID: 1733556
1991
1991
Phase II Trial of Cisplatin, Adriamycin, and Etoposide for Metastatic Endometrial Adenocarcinoma
M. Piver
,
J. Fanning
,
T. Baker
American Journal of Clinical Oncology
1991
Corpus ID: 38402415
Twenty patients with metastatic or recurrent endometrial adenocarcinoma not amenable to surgery or radiation were treated with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE